- Home
- RLAY vs RNST Comparison
RLAY vs RNST Comparison
Compare RLAY & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | RNST |
|---|---|---|
| Founded | 2015 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.0B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RLAY | RNST |
|---|---|---|
| Price | $19.76 | $41.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $19.50 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 2.1M | 524.7K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ 1.88 |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $31.72 |
| Revenue Next Year | $324.03 | $4.67 |
| P/E Ratio | ★ N/A | $22.07 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $3.44 | $33.04 |
| 52 Week High | $21.27 | $44.54 |
Technical Indicators
Market Signals| Indicator | RLAY | RNST |
|---|---|---|
| Relative Strength Index (RSI) | 54.17 | 36.07 |
| Support Level | $18.02 | $40.85 |
| Resistance Level | $20.59 | $41.88 |
| Average True Range (ATR) | 0.93 | 0.78 |
| MACD | -0.09 | -0.27 |
| Stochastic Oscillator | 48.31 | 12.97 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.